Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Consolidated Net Income: 2013-2024

Historic Consolidated Net Income for ProQR Therapeutics N.V (PRQR) over the last 12 years, with Dec 2024 value amounting to -$29.7 million.

  • ProQR Therapeutics N.V's Consolidated Net Income fell 44.50% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.2 million, marking a year-over-year decrease of 79.87%. This contributed to the annual value of -$29.7 million for FY2024, which is 1.11% up from last year.
  • According to the latest figures from FY2024, ProQR Therapeutics N.V's Consolidated Net Income is -$29.7 million, which was up 1.11% from -$30.0 million recorded in FY2023.
  • In the past 5 years, ProQR Therapeutics N.V's Consolidated Net Income registered a high of -$29.7 million during FY2024, and its lowest value of -$71.9 million during FY2021.
  • Moreover, its 3-year median value for Consolidated Net Income was -$30.0 million (2023), whereas its average is -$41.7 million.
  • Per our database at Business Quant, ProQR Therapeutics N.V's Consolidated Net Income plummeted by 35.19% in 2021 and then spiked by 54.20% in 2023.
  • Over the past 5 years, ProQR Therapeutics N.V's Consolidated Net Income (Yearly) stood at -$53.2 million in 2020, then tumbled by 35.19% to -$71.9 million in 2021, then increased by 8.96% to -$65.5 million in 2022, then soared by 54.20% to -$30.0 million in 2023, then increased by 1.11% to -$29.7 million in 2024.